FOURKITES
16.6.2022 10:25:04 CEST | Business Wire | Press release
Leading real-time supply chain visibility platform FourKites® today announces it has outpaced its annual growth targets in the European, Middle Eastern and African (EMEA) markets. The company achieved 148% growth in shipments over the last 12 months, exceeding its target projections of 100% growth. The number of customers tracking loads with FourKites in EMEA has grown by 59% in the last 12 months, while the number of carriers tracking shipments has grown by 55% in the same period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220616005418/en/
“Over the last year, we’ve invested heavily in Europe — in our team, our partners, our products and our customers. Today’s complex supply chains require global, end-to-end visibility, and the region is vital to global trade,” says FourKites CEO and founder, Mathew Elenjickal. “We’re seeing that investment reflected by our accelerated growth metrics over the last year.”
Some of FourKites’ most recent customer additions include Barilla Group, Beyond Meat, Cardinal Health, Haworth, LyondellBasell, McCain Foods, Roehm, Rove Concepts and Yamaha Motors.
Local investment pays off
In January 2022, FourKites acquired German supply chain visibility provider NIC-place , the market leader in supply chain visibility software solutions specifically designed for transport companies, carriers and logistics service providers. The acquisition created the largest multimodal carrier network in Europe, serving global shippers with the most comprehensive end-to-end global supply chain visibility platform.
In addition, over the last few months, FourKites has been investing in its local teams with seasoned industry veterans to build the infrastructure needed to support its growing European network. Recent senior-level hires include Katja van Trigt, Senior Director Talent & Development EMEA, who comes to FourKites with an enviable record having worked at American Express, Bausch & Lomb and Infoblox.
Jeroen Peijnenburg, Enterprise Account Director, Southern Europe, will lead FourKites’ supply chain visibility operations across the region. He has worked for many years in leadership positions within global, asset-owning carriers and logistics service providers.
Nicu Ciontea, Carrier Manager, based in Amsterdam, will increase carrier support across Europe. Until recently, Nicu led the carrier sales team at CH Robinson in Amsterdam.
Nicholas Mellings, Enterprise Account Director EMEA will lead FourKites’ UK Sales team. Nicholas brings with him 30 years of experience in the transport and logistics industry, the last five of which were spent working for Transporeon.
New offices
FourKites has also been growing its European presence with new offices. The company has opened a larger European headquarters in Amsterdam; a new office in Munich serving the pivotal German market; and an increased presence in Poland to serve the Eastern European carrier market.
“To support our growing network of European shippers and carriers, we have taken the steps necessary to ensure that we have a strong local presence, with highly specialised knowledge of the European market,” says Elenjickal. Elenjickal himself is currently touring in Europe, visiting the new offices, meeting face to face with customers, and personally welcoming FourKites’ new supply chain experts brought onboard to fuel organic growth.
“Europe is rapidly seizing the benefits of supply chain visibility,” he adds. “European businesses are finding that FourKites’ approach is a natural fit with their current needs, and that synergy is what’s creating more transparency, collaboration and resilience in global supply chains.”
“Digitisation is an important step in Dow’s journey toward the implementation of an end-to-end supply chain visibility strategy,” says Kevin Nielen, Logistics Leader, Dow Chemical. “Our strategic partnership with FourKites enables us to digitise and move away from a manual way of working to an integrated technology platform workflow.”
FourKites Europe in numbers
Top five countries by load volume: Belgium, France, Germany, Netherlands and Italy.
148% growth in EMEA shipments over the last 12 months
59% growth in the number of customers tracking loads in EMEA over the last 12 months
55% growth in the number of carriers tracking shipments in EMEA over the last 12 months
2.4 billion km tracked in EMEA in the last 12 months
Ports: Over the last 12 months, FourKites saw a 15% growth in the number of ports tracked in EMEA. We now cover 295 ports in the region.
Over the last 12 months, FourKites saw a 92% growth in the number of facilities tracked in EMEA. We now cover 134,000 facilities in the region.
About FourKites
Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220616005418/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom